FUJIFILM Holdings Corporation has identified “Health” as one of the priority areas in its corporate social responsibility (CSR) plan “Sustainable Value Plan 2030” ending March 2031. As part of the Company’s health goals, Fujifilm will improve access to healthcare and medicine around the world through our cutting-edge products and services across prevention, diagnosis and treatment.
Fujifilm plans to issue a social bond offering in April 2022. It will be used to finance the Company’s biopharmaceutical contract development and manufacturing business (Bio CDMO business), which contributes to fulfilling unmet medical needs and improving medical accessibility across the globe.
|
Name |
FUJIFILM Holdings Corporation 16th Series of Unsecured Corporate Bonds (with inter-bond pari passu clause) (Social bonds) |
FUJIFILM Holdings Corporation 17th Series of Unsecured Corporate Bonds (with inter-bond pari passu clause) (Social bonds) |
FUJIFILM Holdings Corporation 18th Series of Unsecured Corporate Bonds (with inter-bond pari passu clause) (Social bonds) |
FUJIFILM Holdings Corporation 19th Series of Unsecured Corporate Bonds (with inter-bond pari passu clause) (Social bonds) |
Timing of issue |
April 20, 2022 |
|||
Launch date |
April 14, 2022 |
|||
Maturity |
3 years |
5 years |
7 years |
10 years |
Issue amount |
40 billion yen |
40 billion yen |
20 billion yen |
20 billion yen |
Interest rate |
0.100% |
0.195% |
0.304% |
0.374% |
Use of proceeds |
Refinance existing investments related to capital investments for new manufacturing sites, M&A, manufacturing capacity expansion and development for high-efficiency and high-productivity technologies, etc., on Bio CDMO business |
|||
Lead managers |
Daiwa Securities Co. Ltd. (book runner) Nomura Securities Co., Ltd. Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. |
|||
Structuring agent* |
Daiwa Securities Co. Ltd. |
|||
Second party opinoin |
DNV Business Assurance Japan K.K. |
|||
Credit ratings |
AA(R&I)、A2(MDY) |
*Entities that assist with the issuance of Social Bonds by undertaking tasks such as drawing up the framework for the bond issuance and obtaining a second party opinion.